Effect of Fibular Head Manipulation on Improving Knee Joint Pain and Range of Motion in Patients With Knee Osteoarthritis

November 10, 2026 updated by: yasmein mohammed mahmoud, Kafrelsheikh University

The goal of this pre-post randomized controlled experimental trial is to examine the effect of fibular head mobilization and manipulation on knee pain, stiffness, and range of motion (ROM) in patients with knee osteoarthritis. The study focuses on 40 participants of both genders, ranging in age from 25 to 65 years.

Main Questions

  • Does fibular head mobilization improve knee pain and range of motion in patients with knee osteoarthritis?
  • What is the impact of fibular head mobilization on knee stiffness and joint function?

Study Design and Comparison

Researchers will compare a treatment group receiving a one-shot manipulation of the head of fibula against a comparison/control group (with study procedures also noting randomized allocation approaches).

Participant Tasks and Evaluation

Participants will:

  • Be randomly assigned into two equal groups of 20 patients each.
  • Have their knee range of motion measured using an electronic goniometer.
  • Have their knee pain measured using a numeric scale.
  • Have their knee function assessed using a knee joint functional index.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants must have knee joint osteoarthritis (OA).
  • Participants must be between 25 and 65 years of age.
  • Both genders are eligible to participate.
  • Participants must sign a consent form according to the Helsinki Protocol.

Exclusion Criteria:

  • A history of recent lower extremity surgery (such as knee replacement, arthroscopy, or ligament reconstruction) in the affected leg.
  • Acute knee trauma, bone fracture, or severe ligamentous instability (such as acute ACL or collateral ligament tears).
  • Inflammatory or systemic arthritic conditions other than osteoarthritis (such as rheumatoid arthritis, gout, or ankylosing spondylitis).
  • Known local contraindications to manual therapy or manipulation around the proximal fibula (such as local skin infection, active tumor, or severe osteoporosis).
  • History of proximal fibular fracture or existing peroneal nerve palsy/injury.
  • Neurological conditions affecting lower limb sensation or motor function (such as stroke, peripheral neuropathy, or radiculopathy).
  • Received physical therapy, intra-articular injections (such as corticosteroids or hyaluronic acid), or other targeted treatments for knee pain within the past 4 to 6 weeks.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Fibular Head Manipulation Group

Participants in this group will receive a one-shot manipulation of the head of the fibula

Participants receive a single session (one-shot) of fibular head manipulation to examine its effects on knee pain, range of motion, and stiffness

No Intervention: Control Group

control group will not receive any treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Knee range of motion will be measured by electronic goniometer
Time Frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)

Secondary Outcome Measures

Outcome Measure
Time Frame
Knee pain will be measured by numeric anlage scale
Time Frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
Knee function will be assessed by knee joint functional index
Time Frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Mohammed Abdelaziz Emam, master degree, Ass.lecturer, faculty of physical therapy, kafr elshiekh university
  • Principal Investigator: Yasmein Mohammed Mahmoud, PhD, faculty of physical therapy, kafr elshiekh university
  • Principal Investigator: Reda Fathi Elbosaty, master degree, Ass.lecturer, faculty of physical therapy, kafr elshiekh university

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 10, 2026

Primary Completion (Estimated)

December 10, 2026

Study Completion (Estimated)

December 11, 2026

Study Registration Dates

First Submitted

November 10, 2026

First Submitted That Met QC Criteria

November 10, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 10, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • KFSIRB200-1209

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Data will be shared upon reasonable request from the principal investigator.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.